Emcure Pharmaceuticals Ltd. logo

Emcure Pharmaceuticals Ltd. Emcure Pharma

Emcure Pharmaceuticals Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.

₹ 0.00

0.00 (0.00)%

Ex-DatePurpose

07-11-2024

Quarterly Results

06-02-2025

Quarterly Results

22-05-2025

Quarterly Results & Final Dividend & Audited Results

11-11-2025

Quarterly Results

04-02-2026

Quarterly Results

05-05-2026

Audited Results & Final Dividend

06-08-2026

Quarterly Results

03-11-2026

Quarterly Results

News

04-NOV-2026

Emcure Pharmaceuticals zooms on reporting 34% rise in Q2 consolidated net profit

The total consolidated income of the company has increased by 24.23% at Rs 2,823.73 crore for Q2FY27

02:39 PM
04-NOV-2026

Emcure Pharmaceuticals reports 34% rise in Q2 consolidated net profit

The total consolidated income of the company has increased by 24.23% at Rs 2,823.73 crore for Q2FY27

02:23 PM
04-NOV-2026

Emcure Pharma - Quaterly Results

12:00 AM
03-NOV-2026

Emcure Pharmaceuticals informs about investor presentation

04:52 PM
03-NOV-2026

Emcure Pharma reports Profit after tax of Rs 2484.28 Mln, in the September 2026 quarter

01:54 PM
10-AUG-2026

Emcure Pharmaceuticals moves up on getting EIR from USFDA for Sanand facility

The USFDA conducted this inspection from May 06, 2026 to May 15, 2026

12:07 PM
10-AUG-2026

Emcure Pharmaceuticals gets EIR from USFDA for Sanand facility

The USFDA conducted this inspection from May 06, 2026 to May 15, 2026

11:48 AM
07-AUG-2026

Emcure Pharma - Quaterly Results

12:00 AM
06-AUG-2026

Emcure Pharma reports Profit after tax of Rs 2001.08 Mln, in the June 2026 quarter

01:51 PM
21-JUL-2026

Emcure soars on getting nod to market Poviztra for treatment of non-cirrhotic MASH

The approval enables Emcure to offer the new indication through Poviztra, expanding access to innovator semaglutide for patients living with a progressive liver disease

03:02 PM
21-JUL-2026

Emcure gets nod to market Poviztra for treatment of non-cirrhotic MASH

The approval enables Emcure to offer the new indication through Poviztra, expanding access to innovator semaglutide for patients living with a progressive liver disease

02:27 PM
14-JUL-2026

Emcure Pharmaceuticals rises on inking pact to acquire remaining 12.05% stake in Gennova

The Gennova will become a wholly-owned subsidiary of the company after completion of the transaction

11:40 AM
14-JUL-2026

Emcure Pharmaceuticals to acquire remaining 12.05% stake in Gennova

The Gennova will become a wholly-owned subsidiary of the company after completion of the transaction

11:27 AM
03-JUL-2026

Emcure Pharmaceuticals informs about acquisition

11:47 AM
12-JUN-2026

Emcure Pharmaceuticals informs about investor presentation

10:12 AM
10-JUN-2026

Kotak Mahindra Mutual Fund buys stake worth Rs 612 crore in Emcure Pharmaceuticals

Kotak Mahindra Mutual Fund has bought 36 lakh equity shares at price of Rs 1,700 apiece

01:05 PM
16-MAY-2026

USFDA concludes cGMP inspection at Emcure Pharmaceuticals’ Gujarat facility

At the conclusion of the inspection, the company was issued a Form 483 with 7 observation(s)

06:25 PM
08-MAY-2026

Emcure Pharmaceuticals informs about ESG rating

03:17 PM
06-MAY-2026

Emcure Pharma - Quaterly Results

12:00 AM
05-MAY-2026

Emcure Pharmaceuticals informs about change in management

05:10 PM
05-MAY-2026

Emcure Pharma reports Profit after tax of Rs 2336.97 Mln, in the March 2026 quarter

02:06 PM
02-APR-2026

Emcure Pharmaceuticals reduces Poviztra dose price to expand patient access

The reduced price would be starting at Rs 3,999 per month

04:45 PM
10-MAR-2026

Emcure Pharmaceuticals informs about clarification on volume movement letter

04:14 PM
04-MAR-2026

Emcure Pharmaceuticals moves up on signing distribution agreement with Roche

Emcure will distribute Roche’s established and globally recognised brands in the nephrology and transplant segment in India

09:28 AM
02-MAR-2026

Emcure Pharmaceuticals signs distribution agreement with Roche

Emcure will distribute Roche’s established and globally recognised brands in the nephrology and transplant segment in India

03:51 PM
05-FEB-2026

Emcure Pharma - Quaterly Results

12:00 AM
04-FEB-2026

Emcure Pharma reports Profit after tax of Rs 2588.51 Mln, in the December 2025 quarter

01:40 PM
22-DEC-2025

Emcure Pharmaceuticals inches up on launching semaglutide injection ‘Poviztra’ across India

It comes in a state-of-the-art pen device that provides the convenience of simple administration of precise dosing

12:50 PM
22-DEC-2025

Emcure Pharmaceuticals launches semaglutide injection ‘Poviztra’ across India

It comes in a state-of-the-art pen device that provides the convenience of simple administration of precise dosing

12:39 PM
22-DEC-2025

Emcure Pharmaceuticals informs about press release

12:29 PM
27-NOV-2025

Emcure Pharmaceuticals informs about disclosure

05:29 PM
22-NOV-2025

Emcure Pharmaceuticals informs about resignation of company secretary

02:08 PM
19-NOV-2025

Emcure Pharmaceuticals informs about investor presentation

02:24 PM
12-NOV-2025

Emcure Pharma - Quaterly Results

12:00 AM
11-NOV-2025

Emcure Pharma reports Profit after tax of Rs 1176.22 Mln, in the September 2025 quarter

01:35 PM
10-NOV-2025

Emcure Pharma, Novo Nordisk India join hands to launch Poviztra in India

As part of the agreement, the company will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra, semaglutide injection 2.4 mg, in India

12:57 PM
06-OCT-2025

Emcure Pharmaceuticals surges on acquiring 20.42% stake in Zuventus Healthcare

Zuventus become a wholly owned subsidiary of the company

09:43 AM
04-OCT-2025

Emcure Pharmaceuticals acquires 20.42% stake in Zuventus Healthcare

Zuventus become a wholly owned subsidiary of the company

11:15 AM
07-AUG-2025

Emcure Pharmaceuticals informs about outcome of board meeting

02:57 PM
07-AUG-2025

Emcure Pharma reports Profit after tax of Rs 1227.89 Mln, in the June 2025 quarter

01:42 PM
07-AUG-2025

Emcure Pharma - Quaterly Results

01:42 PM
07-AUG-2025

Emcure Pharma - Quaterly Results

01:42 PM
07-AUG-2025

Emcure Pharma - Quaterly Results

01:42 PM
17-JUL-2025

Emcure Pharmaceuticals gains on entering into agreement with Sanofi India

Emcure will exclusively distribute and promote the company’s OAD range of products that include well-established brands like Amaryl and Cetapin

09:43 AM
17-JUL-2025

Emcure Pharmaceuticals enters into agreement with Sanofi India

Emcure will exclusively distribute and promote the company’s OAD range of products that include well-established brands like Amaryl and Cetapin

09:21 AM
10-JUL-2025

USFDA concludes PAI at Emcure Pharmaceuticals’ Gujarat manufacturing facility

The inspection concluded without issuance of Form 483 (zero observations)

10:11 AM
04-JUL-2025

Emcure Pharmaceuticals incorporates wholly owned subsidiary

Earlier, the Board of Directors of the company at its meeting held on June 21, 2025, had approved the same

06:06 PM
04-JUL-2025

Emcure Pharmaceuticals informs about incorporation of WOS

05:21 PM
23-JUN-2025

Emcure Pharmaceuticals jumps on getting nod for acquiring 20.42% stake of Zuventus Healthcare

The Board of Directors of the company at its meeting held on June 21, 2025, has approved the same

11:35 AM
21-JUN-2025

Emcure Pharmaceuticals gets nod to incorporate wholly owned subsidiary

The Board of Directors of the company at its meeting held on June 21, 2025, has approved the same

05:22 PM
21-JUN-2025

Emcure Pharmaceuticals informs about updates

04:21 PM
21-JUN-2025

Emcure Pharmaceuticals informs about press release

04:14 PM
21-JUN-2025

Emcure Pharmaceuticals informs about acquisition

03:38 PM
21-JUN-2025

Emcure Pharmaceuticals informs about outcome of board meeting

02:05 PM
21-JUN-2025

Emcure Pharmaceuticals gets nod for acquiring 20.42% stake of Zuventus Healthcare

The Board of Directors of the company at its meeting held on June 21, 2025, has approved the same

01:00 PM
03-JUN-2025

Emcure Pharmaceuticals inks pact to purchase electricity generated from TUPL

Cost of acquisition is Rs 3.72 crore

12:00 PM
23-MAY-2025

Emcure Pharmaceuticals touches the roof on getting nod to incorporate wholly-owned subsidiary

The Board of Directors of the Company in their meeting held May 22, 2025, has approved the same

10:20 AM
23-MAY-2025

Emcure Pharmaceuticals gets nod to incorporate wholly-owned subsidiary

The Board of Directors of the Company in their meeting held May 22, 2025, has approved the same

09:27 AM
22-MAY-2025

Emcure Pharmaceuticals informs about change in management

05:00 PM
22-MAY-2025

Emcure Pharma - Quaterly Results

02:28 PM
22-MAY-2025

Emcure Pharma - Quaterly Results

02:28 PM
22-MAY-2025

Emcure Pharma reports Profit after tax of Rs 1395.57 Mln, in the March 2025 quarter

02:28 PM
22-MAY-2025

Emcure Pharma - Quaterly Results

02:28 PM
21-APR-2025

Emcure Pharmaceuticals gets EIR for Pune manufacturing facility

USFDA has classified the inspection of the said facility as ‘Voluntary Action Indicated’

10:22 AM
04-APR-2025

Emcure Pharmaceuticals’ arm inks pact with Manx Healthcare

Under the APA, Tillomed will acquire Manx’s product portfolio inclusive of relevant Dossiers, Marketing Authorisations, Intellectual Property and the relevant stocks

03:45 PM
02-APR-2025

Emcure Pharmaceuticals’ arm inks in-licensing agreement with WiQo

The collaboration is set to redefine the landscape of non-invasive skin treatments in the region

12:39 PM
11-MAR-2025

Emcure Pharmaceuticals gains on expanding OTC Portfolio with Arth Supplements

Emcure has partnered with acclaimed actor and women’s health advocate Vidya Balan

10:37 AM
10-MAR-2025

Emcure Pharmaceuticals expands OTC Portfolio with Arth Supplements

Emcure has partnered with acclaimed actor and women’s health advocate Vidya Balan

05:45 PM
06-FEB-2025

Emcure Pharma - Quaterly Results

03:04 PM
06-FEB-2025

Emcure Pharma - Quaterly Results

03:04 PM
06-FEB-2025

Emcure Pharma reports Profit after tax of Rs 502.04 Mln, in the December 2024 quarter

03:04 PM
23-JAN-2025

Emcure Pharmaceuticals informs about press release

05:36 PM
23-JAN-2025

Emcure Pharmaceuticals inaugurates R&D centre in Gujarat

The new ERC facility is designed to accelerate pharmaceutical innovation with state-of-the-art laboratories and advanced equipment for each of the dosage forms

03:45 PM
10-JAN-2025

Emcure Pharmaceuticals informs about compliance certificate

12:46 PM
23-NOV-2024

Emcure Pharmaceuticals informs about newspaper publication

11:38 AM
07-NOV-2024

Emcure Pharma - Quaterly Results

03:41 PM
07-NOV-2024

Emcure Pharma - Quaterly Results

03:41 PM
07-NOV-2024

Emcure Pharma reports Profit after tax of Rs 869.21 Mln, in the September 2024 quarter

03:41 PM
07-NOV-2024

Emcure Pharma - Quaterly Results

03:41 PM
03-OCT-2024

Emcure Pharmaceuticals informs about press release

12:53 PM
03-OCT-2024

Emcure Pharmaceuticals signs agreement with Gilead Sciences Ireland UC

This strategic partnership underscores Emcure’s commitment to innovative affordable global healthcare

11:30 AM
26-SEP-2024

Emcure Pharmaceuticals informs about closure of trading window

04:32 PM
16-SEP-2024

Emcure Pharmaceuticals inches up on getting nod to incorporate wholly-owned subsidiary

A Committee of the Board of Directors of the Company in their meeting held on September 13, 2024, has inter-alia approved the same

02:21 PM
14-SEP-2024

Emcure Pharmaceuticals gets nod to incorporate wholly-owned subsidiary

A Committee of the Board of Directors of the Company in their meeting held on September 13, 2024, has inter-alia approved the same

03:03 PM